Non-optimal methodology questions indirect treatment comparison of dupilumab vs. other biologics in severe asthma. Bourdin A, Molinari N. Respir Med 2022;191:105999.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Bourdin A, Molinari N. Non-optimal methodology questions indirect treatment comparison of dupilumab vs. other biologics in severe asthma. Respir Med 2022;191:105999.
PMID: 35090692